Stroke Prevention & Treatment Center
The BMC Stroke Prevention and Treatment Center is dedicated to providing the most advanced techniques and technologies to foster better outcomes for stroke care. The Stroke Center emphasizes acute intervention and is engaged in clinical trials with the goal of optimizing outcomes for stroke patients.
As a certified Primary Stroke Center, we provide rapid response in diagnosing and treating stroke patients. Advanced radiologic techniques such as CT angiography, diffusion and perfusion MR imaging, and cerebral angiography are available to aid in quick and accurate diagnosis. In addition, our highly-specialized team of stroke experts collaborate at all stages of treatment using state-of-the-art research and technology available. Therapies include medical treatments, advanced neurosurgical techniques, and interventional neuroradiology procedures. These unique capabilities are essential to the realization of our ultimate goal — to provide outstanding stroke care to our patients and our community.
Stroke Survivor Support Group Meetings
The Neurology Department Stroke Service at Boston University Medical Center hosts a monthly Stroke Survivor Support Group. The group meets the 2nd Friday of every month. Each meeting features guest speakers from BMC or from within the local Boston community. Caregivers are welcome and encouraged to join us.
Carlos S. Kase, MD
Boston Med Flight is a non-profit organization that transports patients in need of medical attention, regardless of their ability to pay and is financially supported in part by a number of Boston hospitals.
Smith EE, Hassan KA, Fang J, Selchen D, Kapral MK, Saposnik G, on behalf of the Investigators of the Registry of the Canadian Stroke Network (RCSN) for the Stroke Outcome Research Canada (SORCan) Working Group. Do all ischemic stroke subtypes benefit from organized inpatient stroke care? NEUROLOGY 2010;75:456-462
Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, Clark W, Budzik R, Zaidat OO; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012;380(9849):1241-9.
Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, Liebeskind DS, Smith WS; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012;380(9849):1231-40.